The Continuous Renal Replacement Therapy (CRRT) market had a value of US$1 billion in 2021, and is predicted to reach US$ 1.68 billion by 2027, growing at a CAGR of 7.7% between 2021 and 2027. CRRT involves the removal of solutes from the blood using hemofiltration, hemodialysis, or both, and differs from other renal replacement therapies like Intermittent Hemodialysis (IHD), as it can last up to 24 hours in an ICU.
The major players in the market are incorporating technological advancements in acute therapy. In 2019, Baxter International Inc. introduced their TherMax blood warmer and PrisMax system for TPE and continuous renal replacement therapy. Software integration is also being explored as a unique method to execute CRRT safely and effectively. Baxter's PRISMAFLEX system and B. Braun's Diapact Continuous Renal Replacement Therapy (CRRT) allow for crucial blood filtration, and offer adaptable platforms for individualized treatments at the patients' convenience.
Competitive Landscape:
Some of the key players featured in the report include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA; Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.
Get More Details@ https://www.futuremarketinsights.com/reports/continuous-renal-replacement-therapy-market
Segmentation:
The report offers a comprehensive taxonomy of the continuous renal replacement therapy market based on product type, end user and region. Continuous renal replacement therapy is sold in two types: systems and consumables. The consumables segment covers various types of hemofilter sets, solutions and other accessories.
Increasing healthcare spending in emerging nations is predicted to foster the formation of new multi-specialties in dialysis centres and hospitals, hence increasing demand for CRRT. The market for continuous renal replacement treatment has been studied in several regions, including North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and the Middle East and Africa.
According to the report, the global continuous renal replacement therapy market was valued at ~US$ 865 Mn in 2018, and is projected to expand at a CAGR of ~7% during the forecast period.Global Continuous Renal Replacement Therapy Market: OverviewContinuous renal replacement therapy (CRRT) is a preferred modality for managing hemodynamically patients suffering from acute kidney injury.
Moreover, surge in the number of dialysis centers across the world is expected to propel the global continuous renal replacement therapy market.Europe dominated the global continuous renal replacement therapy market in 2018, and the trend is anticipated to continue during the forecast period.
However, shortage of trained staff and high cost of CRRT systems are likely to hamper the continuous renal replacement therapy market in the region during the forecast period.Asia Pacific is expected to be a highly lucrative continuous renal replacement therapy market during the forecast period, owing to increasing healthcare infrastructure, along with rise in the incidence of acute kidney injury in the region.Request COVID Analysis on Continuous Renal Replacement Therapy Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=10298 Rise in Incidence of Diabetes and Hypertension to Drive MarketIncreasing incidence of chronic diseases, such as diabetes and hypertension, fuels the risk of developing acute kidney injury.
Hypertension causes around 9.4 million deaths globally every year.
The development of fourth-generation continuous renal replacement therapy devices, such as ACUsmart, offers a smart and optimal device for critically-ill patients.Continuous Venovenous Haemofiltration (CVVH) Mode to Lead CRRT Market Continuous venovenous hemofiltration (CVVHF) is the most preferred technique.
CVVH is more effective than continuous venovenous haemodiafiltration (CVVHDF), and may be associated with fewer complications.
Over the last few years, there have been noteworthy technological developments in the delivery of renal replacement therapy, principally as it refers to the critically ill patient population.
Renal replacement always utilizes a semi-permeable membrane to accomplish blood purification.
Continuous renal replacement therapy (CRRT) is a widespread optimal for the cure of ICU patients with AKI, particularly for hemodynamically unbalanced circumstances.
CRRT is carried out for about 24 hours in an ICU, making it relatively different from traditional renal replacement therapies that consist of intermittent haemodialysis durable from four to six hours or even at a reduced rate.
Therefore, CRRT was established in an effort to offer artificial kidney support to those patients who could not abide the traditional haemodialysis as traditional intermittent haemodialysis often causes hemodynamic instability in the critically ill patients.
The patients in receipt of CRRT can obtain as much as protein as well as fluid required achieving optimum nutrition.
Continuous Renal Replacement Therapy Market" Continuous Renal Replacement Therapy Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022" ", published by MarketsandMarkets™, The global CRRT market is estimated to reach USD 1.53 billion by 2022; growing at a CAGR of 7.0% during the forecast period.Don’t miss out on business opportunities in Continuous Renal Replacement Therapy MarketIncreasing prevalence of AKI and renal disorders, growing number of ICU patients, rapid growth in the aging population, and clinical advantages of CRRT over intermittent blood purification techniques are some key factors propelling the growth of this market.Continuous Renal Replacement Therapy Market : Target AudienceCRRT manufacturers, suppliers, and distributorsCRRT service providersRenal research laboratoriesRenal associations and organizationsHospitals and critical care unitsAcademic medical centers and universitiesBusiness research and consulting service providersBrowse and in-depth TOC on "NGS Sample Preparation Market" 121 - Tables40 - Figures203 - PagesTo know about the assumptions considered for the study, download the pdf brochureGrowing demand of hemofilters to drive the global CRRT market to reach USD 1.53 billion by 2022Hemofilters or artificial kidneys are one of the major components in a CRRT system.
These filters usually contain a semipermeable membrane in a hollow-fiber design.
This design enables blood to flow inside the hollow fibers and, at the same time, allows the dialysate to flow outside the fibers.
The membrane type and surface area help to determine solute and fluid removal during a CRRT procedure.Continuous Renal Replacement Therapy Market : Key QuestionsWhat are the key growth strategies adopted by major continuous renal replacement therapy market players to maintain their market position across key geographies?What is the existing developmental pipeline of major modalities among key CRRT manufacturers?Growing number of Acute Kidney Injury (AKI) patients is a key trend in CRRT market.
What impact AKI incidences will have on CRRT market during the forecast period?What alternative technologies/therapies are currently being used for AKI worldwide?
What competition they pose for key CRRT market players.
